Haloperidol Decanoate Injection shortage
To Be Discontinued 2 presentations · 1 manufacturers · first FDA posting 2026-01-09 · last update 2026-01-09
Manufacturers: Fresenius Kabi USA, LLC
Stated reasons (per FDA): Not stated
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Haloperidol Decanoate, Injection, 50 mg/1 mL (NDC 63323-469-01) | Fresenius Kabi USA, LLC | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted 01/09/2026 Updated 01/09/2026 Discontinued 01/09/2026 |
| Haloperidol Decanoate, Injection, 50 mg/1 mL (NDC 63323-469-05) | Fresenius Kabi USA, LLC | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted 01/09/2026 Updated 01/09/2026 Discontinued 01/09/2026 |
Get the weekly shortage roundup: a free email of FDA shortage changes (open form)